World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
60604
World Ranking
7499
National Ranking
290

Jan G. M. Klijn publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jan G. M. Klijn sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 349 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jan G. M. Klijn D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jan G. M. Klijn sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 102 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jan G. M. Klijn is affiliated with Erasmus University Rotterdam in the Netherlands. Their academic profile reflects engagement in research activities within this institution.

While specific details on publications, co-authors, and topics of research are not provided, the connection to Erasmus University Rotterdam situates their work within a recognized academic environment. This affiliation may influence their access to research resources and collaborative networks within the Dutch and broader European research contexts.

The absence of listed recent papers suggests limited publicly available bibliographic data or that the scientist's research outputs are not currently indexed in accessible databases. Similarly, there is no detailed information on frequent co-authors or publication venues, indicating that either collaboration networks or publication records are not documented in the provided data.

There are no awards recorded for Jan G. M. Klijn, which might reflect either a focus on work that has yet to be formally recognized or limited documentation of accolades.

The data does not specify main fields of study, subfields, or primary research topics. Therefore, it is not possible to delineate their scientific interests or areas of expertise from the available information.

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.

    Yixin Wang;Jan G M Klijn;Yi Zhang;Anieta M Sieuwerts

  • Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.

    M Baum;A U Budzar;J Cuzick;J Forbes

  • Genome-wide association study identifies novel breast cancer susceptibility loci

    Douglas F. Easton;Karen A. Pooley;Alison M. Dunning;Paul D. P. Pharoah

  • Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition

    Mieke Kriege;Cecile T.M. Brekelmans;Carla Boetes;Peter E. Besnard

  • Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

    Hanne Meijers-Heijboer;Ans van den Ouweland;Jan Klijn;Marijke Wasielewski

  • Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation

    Hanne Meijers-Heijboer;Bert van Geel;Wim L.J. van Putten;Sonja C. Henzen-Logmans

  • Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series,

    Christine Desmedt;Fanny Piette;Sherene Loi;Yixin Wang

  • Subtypes of Breast Cancer Show Preferential Site of Relapse

    Marcel Smid;Yixin Wang;Yi Zhang;Anieta M. Sieuwerts

  • Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.

    Maartje J. Hooning;Akke Botma;Berthe M. P. Aleman;Margreet H. A. Baaijens

  • Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor–Positive Breast Carcinomas Through Genomic Grade

    Sherene Loi;Benjamin Haibe-Kains;Christine Desmedt;Françoise Lallemand

  • The Clinical Significance of Epidermal Growth Factor Receptor (EGF-R) in Human Breast Cancer: A Review on 5232 Patients

    J. G. M. Klijn;P. M. J. J. Berns;P. I. M. Schmitz;J. A. Foekens

  • Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype

    Sunil R. Lakhani;Jorge S. Reis-Filho;Laura Fulford;Frederique Penault-Llorca

  • Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.

    Maxime P. Look;Wim L. J. van Putten;Michael J. Duffy;Nadia Harbeck

  • Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial

    Thomas M. Suter;Marion Procter;Dirk J. van Veldhuisen;Michael Muscholl

  • Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control Study

    Andrea Eisen;Jan Lubinski;Jan Klijn;Pal Moller

  • Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer : a European organization for research and treatment of cancer randomized study with cross-over

    Robert Paridaens;L. Biganzoli;P. Bruning;J.G.M. Klijn

  • BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

    A. Petrij-Bosch;T. Peelen;M. Van Vliet;R. Van Eijk

  • Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer

    John A. Foekens;Anieta M. Sieuwerts;Marcel Smid;Maxime P. Look

  • Survival and Tumour Characteristics of Breast-Cancer Patients with Germline Mutations of BRCA1

    L. C. Verhoog;C. T. M. Brekelmans;C. Seynaeve;L. M. C. Van Den Bosch

Frequent Co-Authors

John A. Foekens
John A. Foekens Erasmus University Rotterdam
Anieta M. Sieuwerts
Anieta M. Sieuwerts Erasmus University Rotterdam
Caroline Seynaeve
Caroline Seynaeve Erasmus University Rotterdam
Peter Devilee
Peter Devilee Leiden University Medical Center
Steven W. J. Lamberts
Steven W. J. Lamberts Erasmus University Rotterdam
Aad Tibben
Aad Tibben Leiden University
John W.M. Martens
John W.M. Martens Erasmus University Rotterdam
Christi J. van Asperen
Christi J. van Asperen Leiden University Medical Center
Ans M.W. van den Ouweland
Ans M.W. van den Ouweland Erasmus University Rotterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring additional healthcare education options can open doors to rewarding careers beyond the traditional path of studying medicine. Many students opt for online degrees in fields such as nursing, health administration, or medical coding, which offer flexibility and diverse professional opportunities.

If you wish to enter the healthcare field with fewer barriers, there are several easy nursing programs to get into. Some of these do not require exams like the TEAS or HESI, which makes them more accessible—find out more about whether do all nursing schools require the teas.

For those interested in the administrative side of healthcare, there are online health administration programs that can be completed at an accelerated pace. Alternatively, working with healthcare data and insurance may suit some students, and there are resources that detail financial aid for medical billing and coding online classes.

These pathways provide flexible, accessible entry points to the healthcare sector, and may be a great fit for various personal and professional goals.

Best Scientists Citing Jan G. M. Klijn

Recently Published Articles